To test our findings in a more physiologically relevant model, we utilized parental KOLF 2.1J iPSCs and KOLF 2.1J iPSCs with homozygous CRISPR/Cas9 knock-in of VCP variant p.R159H (from the iPSC Neurodegenerative Disease Initiative). The gene discussed is VCP; the disease is glycogen storage disease VI.